Primary |
Product Used For Unknown Indication |
53.1% |
Drug Use For Unknown Indication |
18.8% |
Suicide Attempt |
15.0% |
Sedation |
2.3% |
Acute Myeloid Leukaemia |
1.5% |
Accidental Exposure |
1.2% |
Insomnia |
1.2% |
Overdose |
1.2% |
Migraine |
1.0% |
Angioedema |
0.6% |
Postoperative Analgesia |
0.6% |
Pruritus |
0.6% |
Anaphylactoid Reaction |
0.4% |
Arthropod Bite |
0.4% |
Cellulitis |
0.4% |
Drug Hypersensitivity |
0.4% |
Dystonia |
0.4% |
Hypersensitivity |
0.4% |
Pain |
0.4% |
Pharyngeal Oedema |
0.4% |
|
Toxicity To Various Agents |
23.2% |
Completed Suicide |
18.0% |
Drug Abuse |
14.5% |
Intentional Drug Misuse |
8.7% |
Drug Toxicity |
7.6% |
Death |
6.2% |
Cardio-respiratory Arrest |
3.8% |
Respiratory Arrest |
3.8% |
Accidental Drug Intake By Child |
1.7% |
Overdose |
1.7% |
Suicide Attempt |
1.7% |
Intentional Overdose |
1.4% |
Tachycardia |
1.4% |
Tremor |
1.4% |
Unresponsive To Stimuli |
1.0% |
Ventricular Tachycardia |
1.0% |
Delirium |
0.7% |
Hallucination, Visual |
0.7% |
Hypotension |
0.7% |
Hypoxic-ischaemic Encephalopathy |
0.7% |
|
Secondary |
Product Used For Unknown Indication |
58.3% |
Drug Use For Unknown Indication |
14.4% |
Drug Abuse |
8.0% |
Suicide Attempt |
5.8% |
Germ Cell Cancer |
2.4% |
Prophylaxis |
2.0% |
Ill-defined Disorder |
1.1% |
Nausea |
1.1% |
Acute Myeloid Leukaemia |
0.9% |
Vomiting |
0.8% |
Completed Suicide |
0.7% |
Pain |
0.7% |
Intentional Overdose |
0.6% |
Neoplasm Malignant |
0.5% |
Overdose |
0.5% |
Sedation |
0.5% |
Foetal Exposure During Pregnancy |
0.5% |
Chemotherapy |
0.4% |
Non-hodgkin's Lymphoma |
0.4% |
Pruritus |
0.4% |
|
Toxicity To Various Agents |
21.9% |
Completed Suicide |
14.7% |
Respiratory Arrest |
12.0% |
Drug Toxicity |
9.3% |
Drug Abuse |
9.1% |
Death |
7.3% |
Cardio-respiratory Arrest |
3.9% |
Poisoning |
3.4% |
Intentional Drug Misuse |
3.1% |
Suicide Attempt |
2.4% |
Overdose |
2.1% |
Cardiac Arrest |
1.6% |
Vomiting |
1.6% |
Wrong Technique In Drug Usage Process |
1.3% |
Rash |
1.2% |
Pulmonary Oedema |
1.0% |
White Blood Cell Count Decreased |
1.0% |
Accidental Overdose |
0.9% |
Intentional Overdose |
0.9% |
Restless Legs Syndrome |
0.9% |
|
Concomitant |
Product Used For Unknown Indication |
45.0% |
Drug Use For Unknown Indication |
12.0% |
Premedication |
10.1% |
Prophylaxis |
4.9% |
Pain |
4.0% |
Nausea |
3.1% |
Acute Lymphocytic Leukaemia |
2.8% |
Pulmonary Oedema |
2.5% |
Vomiting |
1.7% |
Hypertension |
1.7% |
Depression |
1.5% |
Breast Cancer |
1.4% |
Anxiety |
1.3% |
Constipation |
1.3% |
Adverse Event |
1.3% |
Non-small Cell Lung Cancer |
1.2% |
Mantle Cell Lymphoma |
1.2% |
Crohn's Disease |
1.1% |
Gastrooesophageal Reflux Disease |
1.0% |
Insomnia |
0.9% |
|
Vomiting |
16.9% |
Pyrexia |
6.7% |
Weight Decreased |
6.7% |
Urticaria |
5.6% |
Rash |
5.0% |
Infusion Related Reaction |
4.8% |
Thrombocytopenia |
4.8% |
Pneumonia |
4.4% |
White Blood Cell Count Decreased |
4.4% |
Pulmonary Oedema |
4.2% |
Urinary Tract Infection |
4.2% |
Hypersensitivity |
4.0% |
Tachycardia |
4.0% |
Sepsis |
3.8% |
Tremor |
3.8% |
Wheezing |
3.8% |
Septic Shock |
3.6% |
Off Label Use |
3.4% |
Nausea |
3.2% |
Pruritus |
3.2% |
|
Interacting |
Product Used For Unknown Indication |
50.0% |
Retinoblastoma |
10.0% |
Bronchospasm |
7.5% |
Ill-defined Disorder |
7.5% |
Contrast Media Allergy |
5.0% |
Hypotension |
5.0% |
Delirium |
2.5% |
Imaging Procedure |
2.5% |
Leukocoria |
2.5% |
Ocular Vasculitis |
2.5% |
Pruritus |
2.5% |
Thrombosis |
2.5% |
|
Rash |
38.5% |
Drug Interaction |
15.4% |
Acute Generalised Exanthematous Pustulosis |
7.7% |
Faeces Discoloured |
7.7% |
Nausea |
7.7% |
Neurotoxicity |
7.7% |
Overdose |
7.7% |
Vasospasm |
7.7% |
|